RPID PE Ratio & Valuation,Is RPID Overvalued

RPID Relative Valuation

RPID's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, RPID is overvalued; if below, it's undervalued.

Historical Valuation

Rapid Micro Biosystems Inc (RPID) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.33. The fair price of Rapid Micro Biosystems Inc (RPID) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：3.47

Fair

-4.14

-3.06

EV/EBITDA

Rapid Micro Biosystems Inc. (RPID) has a current EV/EBITDA of -3.06. The 5-year average EV/EBITDA is -2.01. The thresholds are as follows: Strongly Undervalued below -13.58, Undervalued between -13.58 and -7.79, Fairly Valued between 3.77 and -7.79, Overvalued between 3.77 and 9.55, and Strongly Overvalued above 9.55. The current Forward EV/EBITDA of -3.06 falls within the Historic Trend Line -Fairly Valued range.

-2.92

EV/EBIT

Rapid Micro Biosystems Inc. (RPID) has a current EV/EBIT of -2.92. The 5-year average EV/EBIT is -1.81. The thresholds are as follows: Strongly Undervalued below -12.21, Undervalued between -12.21 and -7.01, Fairly Valued between 3.39 and -7.01, Overvalued between 3.39 and 8.60, and Strongly Overvalued above 8.60. The current Forward EV/EBIT of -2.92 falls within the Historic Trend Line -Fairly Valued range.

3.88

Rapid Micro Biosystems Inc. (RPID) has a current PS of 3.88. The 5-year average PS is 6.34. The thresholds are as follows: Strongly Undervalued below -9.75, Undervalued between -9.75 and -1.71, Fairly Valued between 14.38 and -1.71, Overvalued between 14.38 and 22.42, and Strongly Overvalued above 22.42. The current Forward PS of 3.88 falls within the Historic Trend Line -Fairly Valued range.

-4.56

P/OCF

Rapid Micro Biosystems Inc. (RPID) has a current P/OCF of -4.56. The 5-year average P/OCF is -3.53. The thresholds are as follows: Strongly Undervalued below -12.17, Undervalued between -12.17 and -7.85, Fairly Valued between 0.79 and -7.85, Overvalued between 0.79 and 5.12, and Strongly Overvalued above 5.12. The current Forward P/OCF of -4.56 falls within the Historic Trend Line -Fairly Valued range.

-4.40

P/FCF

Rapid Micro Biosystems Inc. (RPID) has a current P/FCF of -4.40. The 5-year average P/FCF is -3.19. The thresholds are as follows: Strongly Undervalued below -12.13, Undervalued between -12.13 and -7.66, Fairly Valued between 1.28 and -7.66, Overvalued between 1.28 and 5.74, and Strongly Overvalued above 5.74. The current Forward P/FCF of -4.40 falls within the Historic Trend Line -Fairly Valued range.

Rapid Micro Biosystems Inc (RPID) has a current Price-to-Book (P/B) ratio of 3.48. Compared to its 3-year average P/B ratio of 0.95 , the current P/B ratio is approximately 267.77% higher. Relative to its 5-year average P/B ratio of 1.00, the current P/B ratio is about 247.14% higher. Rapid Micro Biosystems Inc (RPID) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -96.64%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -74.60% , the current FCF yield is about -100.00% lower.

3.52

P/B

Median3y

0.95

Median5y

1.00

-25.09

FCF Yield

Median3y

-96.64

Median5y

-74.60

Competitors Valuation Multiple

The average P/S ratio for RPID's competitors is , providing a benchmark for relative valuation. Rapid Micro Biosystems Inc Corp (RPID) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 3.08%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of RPID increased by 291.11% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -0.90 to -3.52.

The secondary factor is the Revenue Growth, contributed 3.08%to the performance.

Overall, the performance of RPID in the past 1 year is driven by P/E Change. Which is more unsustainable.

3.08%

7.60M → 7.84M

Revenue Growth

-1.43%

-148.91 → -146.78

Margin Expansion

289.46%

-0.90 → -3.52

P/E Change

291.11%

0.90 → 3.52

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Rapid Micro Biosystems Inc (RPID) currently overvalued or undervalued?

What is Rapid Micro Biosystems Inc (RPID) fair value?

RPID's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Rapid Micro Biosystems Inc (RPID) is between NaN to NaN according to relative valuation methord.

How does RPID's valuation metrics compare to the industry average?

What is the current P/B ratio for Rapid Micro Biosystems Inc (RPID) as of Dec 17 2025?

As of Dec 17 2025, Rapid Micro Biosystems Inc (RPID) has a P/B ratio of 3.48. This indicates that the market values RPID at 3.48 times its book value.

What is the current FCF Yield for Rapid Micro Biosystems Inc (RPID) as of Dec 17 2025?

As of Dec 17 2025, Rapid Micro Biosystems Inc (RPID) has a FCF Yield of 0.00%. This means that for every dollar of Rapid Micro Biosystems Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Rapid Micro Biosystems Inc (RPID) as of Dec 17 2025?

As of Dec 17 2025, Rapid Micro Biosystems Inc (RPID) has a Forward P/E ratio of -4.09. This means the market is willing to pay $-4.09 for every dollar of Rapid Micro Biosystems Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Rapid Micro Biosystems Inc (RPID) as of Dec 17 2025?

As of Dec 17 2025, Rapid Micro Biosystems Inc (RPID) has a Forward P/S ratio of 0.00. This means the market is valuing RPID at $0.00 for every dollar of expected revenue over the next 12 months.

RPID Valuation